Development and optimization of gastro retentive floating tablets of dapsone for controlled release
DOI:
https://doi.org/10.56782/pps.551Keywords:
Dapsone, Gastroretentive drug delivery, Floating tablets, Quality by DesignAbstract
The objective of this study was to develop and optimize gastroretentive floating tablets of dapsone using a Quality by Design approach to enhance therapeutic efficacy in leprosy treatment. The tablets were prepared by direct compression using a 3² factorial design, with HPMC K15M (150—250 mg) and NaHCO3 (15—25 mg) as independent variables. The formulations were evaluated for compression parameters, floating characteristics, and drug release profiles, with optimization focused on floating lag time (Y1) and drug release at 12 hours (Y2) as key responses. Further studies assessed release kinetics, formulation stability, and a comparison with a marketed product. The optimized formulation (RF3), composed of 150 mg HPMC K15M and 25 mg NaHCO3, exhibited excellent flow properties (Carr’s index: 15.25%, angle of repose: 26.84°), desirable floating behavior (lag time: 64 seconds, duration: 11.4 hours), and sustained drug release (98.4% over 12 hours). The drug release followed the Higuchi model (R² = 0.9975) with a non-Fickian transport mechanism (n = 0.75). Stability studies under accelerated conditions (40 °C/75% RH for 6 months) confirmed drug content retention of 98.24% and a consistent release profile (97.4% at 12 hours). Overall, the optimized gastroretentive floating tablet formulation demonstrated satisfactory in vitro performance and stability, suggesting promising advantages over conventional dosage forms through extended gastric retention and controlled drug release. While these findings support the potential of this novel formulation for modified dapsone delivery, comprehensive in vivo studies are necessary to validate its therapeutic benefits over existing therapies.
Downloads
References
1. World Health Organization. Interruption of Transmission and Elimination of Leprosy Disease: Technical Guidance. Available online: https://www.who.int (Last accessed on 8 May 2025).
2. Chen, Y.Z.; Li, W.H.; Wu, Q.; Liu, Y.; Wang, X.M.; Xu, Y.Y.; et al. Evaluation of the economic burden of leprosy among migrant and resident patients in Guangdong Province, China. BMC Infect. Dis. 2017, 17, Art. No: 760. DOI: 10.1186/s12879-017-2869-8 DOI: https://doi.org/10.1186/s12879-017-2869-8
3. Temiz, S.A.; Daye, M. Dapsone for the treatment of acne vulgaris: Do the risks outweigh the benefits? Cutan. Ocul. Toxicol. 2022, 41, 60–66. DOI: 10.1080/15569527.2021.2024565 DOI: https://doi.org/10.1080/15569527.2021.2024565
4. Platsidaki, E.; Kontochristopoulos, G. Dapsone. In European Handbook of Dermatological Treatments; Katsambas, A.D., Lotti, T.M., Dessinioti, C., D’Erme, A.M., Eds.; Springer: Cham, Switzerland, 2023; pp. 1645–1651. DOI: 10.1007/978-3-031-15130-9-145. DOI: https://doi.org/10.1007/978-3-031-15130-9_145
5. Khalilzadeh, M.; Shayan, M.; Jourian, S.; Rahimi, M.; Sheibani, M.; Dehpour, A.R. A comprehensive insight into the anti-inflammatory properties of dapsone. Naunyn Schmiedebergs Arch. Pharmacol. 2022, 395, 1509–1523. DOI: 10.1007/s00210-022-02297-1 DOI: https://doi.org/10.1007/s00210-022-02297-1
6. Chaudhari, K.D.; Nimbalwar, M.G.; Singhal, N.S.; Panchale, W.A.; Manwar, J.V.; Bakal, R.L. Comprehensive review on characterizations and application of gastro-retentive floating drug delivery system. GSC Adv. Res. Rev. 2021, 7, 35–44. DOI: 10.30574/gscarr.2021.7.1.0070 DOI: https://doi.org/10.30574/gscarr.2021.7.1.0070
7. Mora-Castaño, G.; Domínguez-Robles, J.; Himawan, A.; Millán-Jiménez, M.; Caraballo, I. Current trends in 3D printed gastroretentive floating drug delivery systems: A comprehensive review. Int. J. Pharm. 2024, 663, Art. No. 124543. DOI: 10.1016/j.ijpharm.2024.124543 DOI: https://doi.org/10.1016/j.ijpharm.2024.124543
8. Vinchurkar, K.; Sainy, J.; Khan, M.A.; Sheetal, M.; Mishra, D.K.; Dixit, P. Features and facts of a gastroretentive drug delivery system: A review. Turk. J. Pharm. Sci. 2022, 19, 476–483. DOI: 10.4274/tjps.galenos.2021.44959 DOI: https://doi.org/10.4274/tjps.galenos.2021.44959
9. Attimarad, M.; Nair, A.B.; Sreeharsha, N.; Al-Dhubiab, B.E.; Venugopala, K.N.; Shinu, P. Development and validation of green UV derivative spectrophotometric methods for simultaneous determination of metformin and remogliflozin. Int. J. Environ. Res. Public Health 2021, 18, Art. No. 448. DOI: 10.3390/ijerph18020448 DOI: https://doi.org/10.3390/ijerph18020448
10. Alburyhi, M.M.; Hamidaddin, M.A.; Noman, M.A.; Saif, A.A.; Yahya, T.A.; Al-Ghorafi, M.A. Rivaroxaban-excipient compatibility studies for advanced drug delivery systems development. Eur. J. Pharm. Med. Res. 2024, 11, 370–404.
11. Alburyhi, M.M.; Noman, M.A.; Saif, A.A.; Al-Ghorafi, M.A.; Yahya, T.A.; Yassin, S.H.; et al. Diclofenac-excipient compatibility studies for advanced drug delivery systems development. World J. Pharm. Res. 2024, 13, 1297–1333. DOI: 10.20959/wjpr202414-33329
12. Kuril, A.K. Differential scanning calorimetry: A powerful and versatile tool for analyzing proteins and peptides. J. Pharm. Res. Int. 2024, 36, 179–187. DOI: 10.9734/jpri/2024/v36i77549 DOI: https://doi.org/10.9734/jpri/2024/v36i77549
13. Fatahi, H.; Claverie, J.; Poncet, S. Thermal characterization of phase change materials by differential scanning calorimetry: A review. Appl. Sci. 2022, 12, Art. No. 12019. DOI: 10.3390/app122312019 DOI: https://doi.org/10.3390/app122312019
14. Parmar, S.; Patel, J.; Patel, N.; Patel, A. Formulation development, optimization and in vitro evaluation of gas-based gastroretentive drug delivery system of anti-diabetic drug. World J. Pharm. Sci. 2022, 10, 64–83. DOI: 10.54037/WJPS.2022.100607
15. Pandey, S.K.; Pudasaini, J.; Parajuli, N.; Singh, R.E.; Shah, K.P.; Adhikari, A.; et al. Formulation and evaluation of floating tablet of nimesulide by direct compression method. Magna Sci. Adv. Res. Rev. 2024, 10, 153–161. DOI: 10.30574/msarr.2024.10.1.0008 DOI: https://doi.org/10.30574/msarr.2024.10.1.0008
16. Chitte, N.; Jadhav, S.; Shinde, S.; Deshmukh, A.; Patil, C. Formulation and evaluation of gastroretentive floating beads of valsartan. Cuest. Fisioter. 2025, 54, 1813–1832.
17. Gopaiah, K.V.; Kumar, J.N.; Teja, M.R.; Lokesh, T.; Sruthi, D.S.; Roja, M.; et al. Development and assessment of hydroxypropyl methylcellulose-based floating tablets for ciprofloxacin HCL using direct compression technique. J. Pharm. Res. Int. 2024, 36, 47–62. DOI: 10.9734/jpri/2024/v36i37506 DOI: https://doi.org/10.9734/jpri/2024/v36i37506
18. Kunnath, K.; Chen, L.; Zheng, K.; Davé, R.N. Assessing predictability of packing porosity and bulk density enhancements after dry coating of pharmaceutical powders. Powder Technol. 2021, 377, 709–722. DOI: 10.1016/j.powtec.2020.09.037 DOI: https://doi.org/10.1016/j.powtec.2020.09.037
19. Kalman, H. Bulk densities and flowability of non-spherical particles with mono-sized and particle size distributions. Powder Technol. 2022, 401, Art. No. 117305. DOI: 10.1016/j.powtec.2022.117305. DOI: https://doi.org/10.1016/j.powtec.2022.117305
20. Schlick-Hasper, E.; Bethke, J.; Vogler, N.; Goedecke, T. Flow properties of powdery or granular filling substances of dangerous goods packagings. Packag. Technol. Sci. 2022, 35, 765–782. DOI: 10.1002/pts.2678 DOI: https://doi.org/10.1002/pts.2678
21. Kaleem, M.A.; Alam, M.Z.; Khan, M.; Jaffery, S.H.I.; Rashid, B. Experimental investigation on accuracy of Hausner ratio and Carr index of powders. Met. Powder Rep. 2021, 76, S50–S54. DOI: 10.1016/j.mprp.2020.06.061 DOI: https://doi.org/10.1016/j.mprp.2020.06.061
22. Jadhav, S.P.; Ahire, S.M.; Shewale, V.V.; Patil, C.D.; Pagar, R.Y.; Sonawane, D.D.; et al. Formulation of tablet of nifedipine co-crystal for enhancement of solubility. Biosci. Biotechnol. Res. Asia 2025, 22, 191–200. DOI: 10.13005/bbra/3353 DOI: https://doi.org/10.13005/bbra/3353
23. Ansari, M.H. Preclinical drug development process: Formulation and development aspects. Int. J. Med. Phar. Sci. 2023, 13, Art. No. 1. DOI: 10.31782/IJMPS.2023.13301 DOI: https://doi.org/10.31782/IJMPS.2023.13301
24. Asrade, B.; Tessema, E.; Tarekegn, A. In vitro comparative quality evaluation of different brands of carbamazepine tablets. BMC Pharmacol. Toxicol. 2023, 24, Art. No. 35. DOI: 10.1186/s40360-023-00670-1 DOI: https://doi.org/10.1186/s40360-023-00670-1
25. Ukwueze, S.E.; Jonathan, C.I.; Ezeh, I.N.; Oti, I.E.; Chukwu, D.E.; Chukwuogor, C.; et al. Formulation and evaluation of diazepam tablet from solidified self-emulsifying drug delivery system. World J. Pharm. Sci. 2021, 9, 150–161. DOI: 10.54037/WJPS.2021.91206 DOI: https://doi.org/10.54037/WJPS.2021.91206
26. Vetrivel, D.; Ilango, K.B.; Bhuvaneswari, S.; Gomathi, P.; Kowsalya Devi, M. In-vitro comparative study of generic vs branded tablets–A review. World J. Pharm. Res. 2023, 12, 419–437. DOI: 10.20959/wjpr202322-30569
27. Sharma, S.; Gupta, S.; Bhardwaj, B.; Sahu, A. A comparative analysis of metformin hydrochloride tablets, both branded and generic. Int. J. Pharm. Sci. Rev. Res. 2023, 16, 4207–4221.
28. Shimu, S.A. Comparative Evaluation of Atorvastatin 20 mg Tablets Marketed in Bangladesh. Bachelor of Pharmacy Thesis, Brac University, Dhaka, Bangladesh, September 2024.
29. Islam, M.R.; Hossain, M.S.; Hossain, M.S.; Islam, M.T.; Sultana, S.; Nijhum, N.; et al. Quality assessment of hydroxychloroquine tablet. Prog. Microbes Mol. Biol. 2023, 6, Art. No. a0000336. DOI: 10.36877/pmmb.a0000336 DOI: https://doi.org/10.36877/pmmb.a0000336
30. Jadhav, S.P.; Patil, D.M.; Sonawane, D.D.; Patil, P.D.; Ghugarkar, P.G.; Saad, M. Formulation of tablet of ivermectin co-crystal. J. Pharm. Negat. Results 2023, 14, 513–520. DOI: 10.47750/pnr.2023.14.S01.60
31. Won, D.H.; Park, H.; Ha, E.S.; Kim, H.H.; Jang, S.W.; Kim, M.S. Optimization of bilayer tablet manufacturing process. Int. J. Pharm. 2021, 605, Art. No. 120838. DOI: 10.1016/j.ijpharm.2021.120838 DOI: https://doi.org/10.1016/j.ijpharm.2021.120838
32. Sanoj, R.; Sunny, S.S.; Mohasin, S.; Jeffisha, F. Innovations in drug release: A review on gastroretentive drug delivery systems. IJPPR.Human 2023, 28, 104–123.
33. Kumar, A.; Srivastava, R. In vitro in vivo studies on floating microspheres. Asian J. Pharm. Clin. Res. 2021, 14, 13–26. DOI: 10.22159/ajpcr.2021.v14i1.39183 DOI: https://doi.org/10.22159/ajpcr.2021.v14i1.39183
34. Ranjan, A.; Jha, P.K. Studying drug release through polymeric controlled release formulations. Mol. Pharm. 2021, 18, 2600–2611. DOI: 10.1021/acs.molpharmaceut.1c00086 DOI: https://doi.org/10.1021/acs.molpharmaceut.1c00086
35. Javed, Q.U.A.; Syed, M.A.; Arshad, R.; Rahdar, A.; Irfan, M.; Raza, S.A.; et al. Prolonged release mucoadhesive tablets of dexamethasone. Pharmaceutics 2022, 14, Art. No. 807. DOI: 10.3390/pharmaceutics14040807 DOI: https://doi.org/10.3390/pharmaceutics14040807
36. González-González, O.; Ramirez, I.O.; Ramirez, B.I.; O’Connell, P.; Ballesteros, M.P.; Torrado, J.J. Drug stability: ICH versus accelerated predictive stability studies. Pharmaceutics 2022, 14, Art. No. 2324. DOI: 10.3390/pharmaceutics14112324 DOI: https://doi.org/10.3390/pharmaceutics14112324
37. Henninger, B.; Plaikner, M.; Zoller, H.; Viveiros, A.; Kannengiesser, S.; Jaschke, W.; et al. Performance of Dixon-based methods for MR liver iron assessment. Eur. Radiol. 2021, 31, 2252–2262. DOI: 10.1007/s00330-020-07291-w DOI: https://doi.org/10.1007/s00330-020-07291-w
38. Scrivens, G. Theory and fundamentals of accelerated predictive stability (APS) studies. In Accelerated Predictive Stability; Gerst, P., Ed.; Elsevier: Amsterdam, The Netherlands, 2018; pp. 39–65. DOI: https://doi.org/10.1016/B978-0-12-802786-8.00003-6
39. Zhou, W.; He, Y.; Liu, F.; Liao, L.; Huang, X.; Li, R.; et al. Carboxymethyl chitosan–pullulan edible films enriched with galangal essential oil. Carbohydr. Polym. 2021, 256, Art. No. 117579. DOI: 10.1016/j.carbpol.2020.117579 DOI: https://doi.org/10.1016/j.carbpol.2020.117579
40. Aminu, N.; Chan, S.Y.; Mumuni, M.A.; Umar, N.M.; Tanko, N.; Zauro, S.A.; et al. Physicochemical compatibility studies of triclosan and flurbiprofen. Future J. Pharm. Sci. 2021, 7, Art. No. 148. DOI: 10.1186/s43094-021-00302-7 DOI: https://doi.org/10.1186/s43094-021-00302-7
41. Diño, S.F.; Edu, A.D.; Francisco, R.G.; Gutierrez, E.; Crucis, P.; Lapuz, A.M.; et al. Drug-excipient compatibility testing of cilostazol. Philipp. J. Sci. 2023, 152, 2129–2137. DOI: 10.56899/152.6A.08 DOI: https://doi.org/10.56899/152.6A.08
42. Almotairi, N.; Mahrous, G.M.; Al-Suwayeh, S.; Kazi, M. Design and optimization of lornoxicam dispersible tablets. Pharmaceuticals 2022, 15, Art. No. 1463. DOI: 10.3390/ph15121463 DOI: https://doi.org/10.3390/ph15121463
43. Bhatia, V.; Dhingra, A.K.; Dass, R.; Chopra, B.; Guarve, K. Formulation and development of escitalopram fast dissolving tablets. Cent. Nerv. Syst. Agents Med. Chem. 2022, 22, 198–213. DOI: 10.2174/1871524922666220624113719 DOI: https://doi.org/10.2174/1871524922666220624113719
44. Al Hablawi, M.F.; Jaffar, I.S. Formulation variables influencing ketoconazole gastroretentive drug delivery system. Al-Rafidain J. Med. Sci. 2024, 7, S15–S23. DOI: 10.54133/ajms.v7i1.867 DOI: https://doi.org/10.54133/ajms.v7i1(Special).867
45. Su’udiyah, U.F.; Sugiyartono. Effect of ethyl cellulose on floating characteristic and ranitidine HCL release from floating tablet. Res. J. Pharm. Technol. 2021, 14, 735–740. DOI: 10.5958/0974-360X.2021.00128.1 DOI: https://doi.org/10.5958/0974-360X.2021.00128.1
46. Jaimini, R.; Jaimini, M. Formulation and optimization of gastro-retentive floating tablets of enalapril maleate and losartan. Trop. J. Pharm. Life Sci. 2025, 12, 01–10. DOI: 10.61280/tjpls.v12i1.170 DOI: https://doi.org/10.61280/tjpls.v12i1.170
47. Moravkar, K.K.; Shah, D.S.; Magar, A.G.; Bhairav, B.A.; Korde, S.D.; Ranch, K.M.; et al. Assessment of pharmaceutical powders flowability. J. Drug Deliv. Sci. Technol. 2022, 71, Art. No. 103265. DOI: 10.1016/j.jddst.2022.103265 DOI: https://doi.org/10.1016/j.jddst.2022.103265
48. Patel, M.; Shelke, S.; Surti, N.; Panzade, P.; Al-Keridis, L.A.; Upadhyay, T.K.; et al. Design, preparation, and in vitro evaluation of gastroretentive floating matrix tablet of mitiglinide. Front. Pharmacol. 2023, 14, Art. No. 1140351. DOI: 10.3389/fphar.2023.1140351 DOI: https://doi.org/10.3389/fphar.2023.1140351
49. Syed, S.M.; Gawale, K.; Farooqui, Z.S. Formulation development and evaluation of gastro retentive matrix tablet of levamisole hydrochloride. Pharm. Biosci. J. 2021, 9, 50–70. DOI: 10.20510/ukjpb/9/i1/1611533539 DOI: https://doi.org/10.20510/ukjpb/9/i1/1611533539
50. Indurkhya, A.; Masheer, K.A. Box–Behnken design for optimization of formulation variables for controlled release gastroretentive tablet of verapamil hydrochloride. Int. J. Appl. Pharm. 2023, 15, 256–263. DOI: 10.22159/ijap.2023v15i1.46489 DOI: https://doi.org/10.22159/ijap.2023v15i1.46489
51. Patel, M.B.; Shaikh, F.; Patel, V.B.; Surti, N. Application of experiential design for framing gastroretentive microsponges of glipizide. Indian J. Pharm. Educ. Res. 2021, 55, 966–978. DOI: 10.5530/ijper.55.4.197 DOI: https://doi.org/10.5530/ijper.55.4.197
52. Patel, A.; Modasiya, M.; Shah, D.; Patel, V. Development and in vivo floating behavior of verapamil HCl intragastric floating tablets. AAPS PharmSciTech 2009, 10, 310–315. DOI: 10.1208/s12249-009-9210-9 DOI: https://doi.org/10.1208/s12249-009-9210-9
53. Lee, Y.S.; Kang, J.S.; Kim, K.M.; Pyo, J.S. Optimization of ticagrelor tablet for gastro-retentive drug delivery using full factorial design. Trop. J. Pharm. Res. 2024, 23, 235–242. DOI: 10.4314/tjpr.v23i2.1 DOI: https://doi.org/10.4314/tjpr.v23i2.1
54. Jadhav, S.P.; Patil, D.M.; Sonawane, D.D.; Gaikwad, V.B.; Patil, P.D.; Ghugarkar, P.G. Formulation development and evaluation of orally disintegrating tablet of clopidogrel bisulphate. Int. J. Res. Pharm. Sci. 2023, 14, 505–512. DOI: 10.26452/ijrps.v14i1.5206
55. Das, S.; Kaur, S.; Rai, V.K. Gastro-retentive drug delivery systems: A recent update on clinical pertinence and drug delivery. Drug Deliv. Transl. Res. 2021, 11, 1849–1857. DOI: 10.1007/s13346-020-00875-5 DOI: https://doi.org/10.1007/s13346-020-00875-5
56. Raja, H.N.; Din, F.U.; Shabbir, K.; Khan, S.; Alamri, A.H.; Al Awadh, A.A.; et al. Sodium alginate-based smart gastro-retentive drug delivery system of revaprazan loaded SLNs. Int. J. Biol. Macromol. 2023, 253, Art. No. 127402. DOI: 10.1016/j.ijbiomac.2023.127402 DOI: https://doi.org/10.1016/j.ijbiomac.2023.127402
57. Mir, A.; Kumar, A.; Alam, J.; Riaz, U. Synthesis and characterization of pH-responsive composite hydrogels for sustained release of amoxicillin drug. Int. J. Biol. Macromol. 2023, 252, Art. No. 126015. DOI: 10.1016/j.ijbiomac.2023.126015 DOI: https://doi.org/10.1016/j.ijbiomac.2023.126015
58. Nigusse, B.; Gebre-Mariam, T.; Belete, A. Design, development and optimization of sustained release floating, bioadhesive and swellable matrix tablet of ranitidine hydrochloride. PLoS ONE 2021, 16, Art. No. e0253391. DOI: 10.1371/journal.pone.0253391 DOI: https://doi.org/10.1371/journal.pone.0253391
59. Sousa, A.S.; Serra, J.; Estevens, C.; Costa, R.; Ribeiro, A.J. Unveiling swelling and erosion dynamics of mirabegron extended release tablets. AAPS PharmSciTech 2024, 25, Art. No. 277. DOI: 10.1208/s12249-024-02994-5. DOI: https://doi.org/10.1208/s12249-024-02994-5
60. Elkomy, M.H.; Abou-Taleb, H.A.; Eid, H.M.; Yassin, H.A. Fabrication and in vitro/in vivo appraisal of metronidazole intra-gastric buoyant sustained-release tablets. Pharmaceutics 2022, 14, Art. No. 863. DOI: 10.3390/pharmaceutics14040863 DOI: https://doi.org/10.3390/pharmaceutics14040863
61. Xi, Z. QBD Approach for Development of Ivermectin-Loaded Gastro-Retentive Sustained Release Tablets as Mass Drug Administration for Malaria Transmission Control. Ph.D. Dissertation, Saint John’s University, Jamaica, New York, USA, 2021.
62. Gaikwad, D.T.; Patil, S.J.; Killedar, S.G.; Wadkar, G.H.; Mali, D.P.; Jadhav, S.A. Formulation and evaluation of domperidone maleate mucoadhesive system using Cassia fistula L. seed mucilage. J. Med. Pharm. Allied Sci. 2022, 11, 5318–5324. DOI: 10.55522/jmpas.V11I5.4203 DOI: https://doi.org/10.55522/jmpas.V11I5.4203
63. Yoshida, T.; Kojima, H. Oral drug delivery systems applied to launched products: Value for the patients and industrial considerations. Mol. Pharm. 2023, 20, 5312–5331. DOI: 10.1021/acs.molpharmaceut.3c00482 DOI: https://doi.org/10.1021/acs.molpharmaceut.3c00482
64. Kim, D.H.; Lee, S.W.; Lee, J.H.; Park, J.W.; Park, S.M.; Maeng, H.J.; et al. Development of gastroretentive floating combination tablets containing amoxicillin trihydrate and levofloxacin. Pharmaceutics 2024, 16, Art. No. 1242. DOI: 10.3390/pharmaceutics16101242 DOI: https://doi.org/10.3390/pharmaceutics16101242
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Rushikesh Mahale, Shivraj Jadhav, Sunil Mahajan
This work is licensed under a Creative Commons Attribution 4.0 International License.
For all articles published in Prospects in Pharmaceutical Sciences copyright is retained by the authors. The journal publishes articles in the Open Access policy, within the CC BY 4.0 licence.
This is a human-readable summary of (and not a substitute for) the license. Disclaimer.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
How to Cite
